Preclinical evidence for an effective therapeutic activity of FL118, a novel survivin inhibitor, in patients with relapsed/refractory multiple myeloma

Saved in:

Bibliographic Details
Published in:	Haematologica (Roma) Vol. 105; no. 2; pp. e80 - e83
Main Authors:	Holthof, Lisa C., van der Horst, Hilma J., van Hal-van Veen, Susan E., Ruiter, Ruud W.J., Li, Fengzhi, Buijze, Marijke, Andersen, Morten N., Yuan, Huipin, de Bruijn, Joost, van de Donk, Niels W.C.J., Lokhorst, Henk M., Zweegman, Sonja, Groen, Richard W.J., Mutis, Tuna
Format:	Journal Article
Language:	English
Published:	Italy Ferrata Storti Foundation 01.02.2020
Subjects:	Benzodioxoles Humans Indolizines Multiple Myeloma - drug therapy Online Only Survivin - antagonists & inhibitors
ISSN:	0390-6078, 1592-8721, 1592-8721
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 content type line 23
ISSN:	0390-6078 1592-8721 1592-8721
DOI:	10.3324/haematol.2018.213314